Sawa, Masashi
Miyamoto, Toshihiro
Kim, Hee-Je
Hiramatsu, Yasushi
Cheong, June-Won
Ikezoe, Takayuki
Naoe, Tomoki
Akashi, Koichi
Morita, Satoshi
Kosako, Masanori
Ikegaya, Moyu
Terada, Wataru
Kadokura, Takeshi
Hill, Jason
Miyawaki, Shuichi
Gill, Stanley C.
Heinloth, Alexandra
Hasabou, Nahla
Funding for this research was provided by:
Astellas Pharma US
Article History
Received: 3 January 2024
Revised: 6 August 2024
Accepted: 21 August 2024
First Online: 6 November 2024
Declarations
:
: Sawa M reports payment/honoraria from Janssen Pharma and Sanofi. Miyamoto T reports payment/honoraria from Takeda Pharmaceutical Co., Otsuka Pharmaceutical Co., Ltd., MSD Co., Ltd, Astellas Pharmaceutical Co., Ltd., Janssen Co., Ltd., Abbvie Pharmaceutical Co., Ltd., and Kyowa Kirin Pharmaceutical Co. Kim H-J reports consulting fees from Astellas and honoraria from Astellas, and participated in advisory boards for Astellas. Cheong J-W reports payment/honoraria from Astellas, Bristol Myers Squibb, Merck, and GSK, and acted in a leadership/fiduciary role for The Korean Society of Hematology, AML/MDS Working Party, and The Korean Society of Blood and Marrow Transplantation. Naoe T reports payment/honoraria from Bristol Myers Squibb, Pfizer, Nippon Shinyaku, Astellas, Otsuka Pharma, and Japan Tissue Engineering. Akashi K reports grants from Asahi Kasei Pharma, Chugai Pharmaceutical, Kyowa Kirin and Sumitomo Pharma, and payment and/or honoraria from Asahi Kasei Pharma, Astellas, AstraZeneca, Abbvie, Kyowa Kirin, Chugai Pharmaceutical, Bristol Myers Squibb and Janssen Pharmaceuticals. Hill J reports stocks with Ligacept, LLC and is an employee of Astellas Pharma Inc. Kosako M, Ikegaya M, Terada W, Kadokura T, Gill SC, Heinloth A and Hasabou N are employees of Astellas Pharma Inc. Ikezoe T is editor of International Journal of Hematology. Hiramatsu Y, Morita S, and Miyawaki S have no disclosures to report.